LeonaBio (LONA) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for LeonaBio
Is LeonaBio a buy right now? The alternative data says hold. This LONA stock analysis is built on the 25+ alternative data signals AltIndex tracks on LeonaBio every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 48/100: a Hold. The stock trades at $5.20 with a $49M market cap.
The data leans positive over the past 90 days — web traffic up 39.9% to 7K monthly visits — but the move hasn’t been broad enough to lift LONA into buy territory yet.
LONA’s broader alt-data profile also covers job postings (1 open roles), headcount (56 employees, according to LinkedIn), and sentiment (100/100). Every signal links to its own page with full history, the LONA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on LONA is just below.
LeonaBio AI Stock Analysis
LeonaBio is a biotechnology company specializing in innovative treatments for genetic disorders and rare diseases. It has garnered significant attention in recent years due to its promising pipeline of pharmaceutical products and a string of strategic partnerships with reputed institutions.
Analysis generated October 3, 2026.
Recent LeonaBio Stock Alerts
|
LeonaBio | October 15 Price is down by -6.3% in the last 24h. |
|
LeonaBio | October 14 Price is down by -8.2% in the last 24h. |
|
LeonaBio | October 13 Price is down by -6.7% in the last 24h. |
|
LeonaBio | October 12 Price is up by 6.1% in the last 24h. |
LeonaBio Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 7K | 39.9% | |
| Job Posts | 1 | 0% | |
| LinkedIn Employees | 56 | 3.7% | |
| Sentiment | 100 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 0% | |
| Stocktwits Mentions | 2 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 0% |
About LeonaBio (LONA)
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
| Price | $5.20 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $49M |
| Year Range | $3 – $12 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest LeonaBio News
View more → |
LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advancesAugust 17 - Advfn.com |
LeonaBio to Participate in Upcoming Medical and Industry Meetings in JuneMay 27 - GlobeNewswire |
|
BNP Paribas gets more bearish on Alten SA, downgrades sharesJuly 30 - Thefly.com |
|
Immuneering Appoints Andrew Gengos as Chief Financial OfficerJune 15 - GlobeNewswire |
|
See LeonaBio’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for LONA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREELeonaBio Earnings & Financial Performance
View all earnings →LeonaBio Insider Trading Activity
View all →| Renninger Robert filed to sell 15,851 shares at $0.0. Mar 4 '26 |
| Litton Mark James filed to sell 57,926 shares at $0.0. Mar 4 '26 |
| San Martin Javier filed to sell 15,887 shares at $0.0. Mar 4 '26 |
| CHURCH KEVIN filed to sell 25,178 shares at $0.0. Mar 4 '26 |
| Worthington Mark filed to sell 18,376 shares at $0.0. Mar 4 '26 |
LeonaBio Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to LeonaBio
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Elicio TherapeuticsELTX |
$1.56 12.4% | $48M | 37 |
 |
DarioHealthDRIO |
$4.82 6.0% | $50M | 35 |
 |
Werewolf TherapeuticsHOWL |
$0.98 1.7% | $48M | 45 |
 |
Kalaris TherapeuticsKLRS |
$2.00 8.7% | $48M | 55 |
 |
MiNK TherapeuticsINKT |
$9.41 5.3% | $51M | 52 |
Explore LeonaBio Data
Frequently Asked Questions: LeonaBio (LONA)
LeonaBio has an AltIndex AI Score of 48/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
48/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of LeonaBio (LONA) stock is $5.20 with a market cap of $49M.
As of today, LeonaBio’s PE (Price to Earnings) ratio is —.
View the latest LeonaBio insider transactions to see recent buying and selling activity by company executives and directors.
Check the LeonaBio congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The LONA stock price chart above shows LeonaBio’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full LeonaBio technical analysis for RSI, moving averages, and more.
See the stocks similar to LeonaBio section on this page for companies in the same industry ranked by market cap and AI Score.
